Pharmaceuticals

As it turns 60, Melmark adds two powerhouse leaders with deep personal ties to its mission, signaling a new era of strategic growth and innovation.

A new AI tool promises to cut SOP updates from days to hours, but how does it stack up in the race to automate regulatory compliance for drug makers?

Amid federal funding threats, state leaders and industry forge a strategic alliance to protect Connecticut’s $7B life sciences sector and fuel innovation.

With the appointment of Kelly Johnston McKee, Science 37 signals a major push to redefine patient experience and operationalize the future of clinical research.

An oral drug for Huntington's disease shows early success, improving patient scores where a decline was expected, fueling hope for a breakthrough treatment.

BioTalent Canada's latest awards highlight how inclusivity, diversity, and equity are becoming key drivers of innovation and profit in the bioscience sector.

Veteran leader Emma Rooth takes charge at PCCA UK, bringing a track record of transformation to the booming personalized medicine market.

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

Roche's CT-388 posts impressive Phase II results, positioning it as a powerful new rival to Zepbound and Wegovy in the booming obesity drug market.

A French biotech is advancing a novel class of drugs that don't just fight cravings but may reverse the deep-seated brain changes caused by addiction.

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

A new study reveals albumin, the most abundant protein in blood, is a powerful weapon against mucormycosis, offering new hope for treating this fatal infection.

The acquisition strengthens the independent distributor's hold on the booming plasma therapy market, promising wider access to critical, complex medications.

Avant Technologies is evaluating a therapy to protect insulin cells from immune attack, a breakthrough that could end the need for harsh drugs.

A new COVID-19 drug targets patients who can't take Paxlovid, while a once-a-month pill could revolutionize how we prevent seasonal influenza.

With new VP of Sales David Florez, Peer AI aims to accelerate its mission of transforming regulatory documentation as the pharma industry moves beyond AI pilots.

Leios Therapeutics partners with BNC Korea, securing a key investment and pathway to Asia's lucrative body contouring market for its 10XB-101 injectable.

A first-in-class oral therapy targeting cellular metabolism has entered patient trials, offering new hope for a disease-modifying treatment for eczema.

On its 50th anniversary, CDMO specialist Coating Place leverages a major investment by appointing two industry veterans to drive its next chapter of expansion.